The IGF-I and Growth Hormone Panel Test is a diagnostic assessment offered by DNA Labs UAE, designed to measure the levels of Insulin-like Growth Factor 1 (IGF-I) and Growth Hormone (GH) in the blood. These hormones play a crucial role in regulating growth, development, and metabolism. The test is particularly important for identifying disorders related to growth hormone deficiencies or excesses, such as gigantism, acromegaly, and dwarfism, as well as evaluating pituitary function.
Priced at 1050 AED, the test involves a simple blood draw, after which the sample is analyzed to determine the concentrations of IGF-I and GH. The results can provide valuable insights into the patient's hormonal balance, helping healthcare providers diagnose conditions, guide treatment decisions, and monitor the effectiveness of interventions aimed at correcting hormonal imbalances.
Immunohistochemistry (IHC) Thyroid Carcinoma Panel Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to aid in the accurate identification and classification of thyroid cancer. This test employs a set of specific antibodies to detect and visualize the presence of certain proteins in tissue samples obtained from the thyroid gland. The presence, absence, or quantity of these proteins can help pathologists determine the type of thyroid carcinoma, providing crucial information that guides treatment decisions.
The IHC Thyroid Carcinoma Panel Test is particularly valuable because thyroid cancers can vary widely in their aggressiveness and response to treatment. By identifying the specific characteristics of the cancer cells, this test enables personalized treatment plans that are tailored to the individual's specific type of thyroid cancer, potentially improving outcomes.
The cost of the Immunohistochemistry Thyroid Carcinoma Panel Test at DNA Labs UAE is 1050 AED. Given the complexity and the specialized nature of this test, it represents a critical investment in the accurate diagnosis and management of thyroid cancer. Patients undergoing this test can expect a detailed analysis of their thyroid tissue, which will aid their healthcare providers in making informed decisions regarding their treatment and management.
The MPL Myeloproliferative Leukemia Gene Mutation Test is a specialized diagnostic examination designed to detect mutations in the MPL gene, which are often associated with certain types of myeloproliferative neoplasms (MPNs). These MPNs are a group of disorders characterized by the excessive production of blood cells in the bone marrow, which can lead to various health issues such as thrombosis, bleeding complications, and in some cases, transformation into acute leukemia. The MPL gene plays a crucial role in the regulation of blood cell production, and mutations in this gene can be indicative of conditions like essential thrombocythemia (ET) and primary myelofibrosis (PMF).
The test is conducted at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. Utilizing advanced molecular techniques, the laboratory ensures precise and reliable results, which are critical for the accurate diagnosis and management of myeloproliferative disorders. The cost of the MPL Myeloproliferative Leukemia Gene Mutation Test is 1050 AED, making it an accessible option for individuals seeking comprehensive insights into their genetic predisposition to these blood disorders. Early detection and diagnosis through such genetic testing can significantly impact treatment decisions and outcomes for affected individuals.
The Phospholipid Syndrome Panel Test is a diagnostic tool used to detect the presence of antiphospholipid antibodies in the blood, which are indicative of antiphospholipid syndrome (APS). APS is an autoimmune disorder characterized by the body's immune system mistakenly attacking normal proteins in the blood, leading to increased risk of blood clots, miscarriage, and other complications. This comprehensive panel test is crucial for diagnosing APS, monitoring the severity of the condition, and guiding treatment decisions.
At DNA Labs UAE, the cost of the Phospholipid Syndrome Panel Test is set at 1050 AED. The test is conducted in a state-of-the-art laboratory setting by a team of experienced professionals, ensuring accurate and reliable results. DNA Labs UAE is known for its commitment to quality, patient care, and the use of advanced diagnostic technologies, making it a preferred choice for individuals seeking thorough and dependable medical testing services.
The "Malaria P.Falciparum Quantitative Test" is a sophisticated diagnostic procedure aimed at quantifying the presence of Plasmodium falciparum parasites in the blood, the most dangerous species among the parasites causing malaria. This test is particularly crucial for diagnosing severe malaria cases and for monitoring treatment efficacy. Conducted at DNA Labs UAE, a state-of-the-art facility known for its precision and reliability, this test employs advanced molecular techniques to provide accurate and quantitative results. The cost of the test is set at 1020 AED, reflecting the sophisticated nature of the technology and expertise involved. This test is a vital tool in the management and control of malaria, especially in regions where P. falciparum is prevalent, offering a crucial step towards timely and effective treatment.
The Proteus vulgaris RNA Detection Qualitative Test is a highly specific and sensitive molecular diagnostic tool designed to identify the presence of RNA from the Proteus vulgaris bacterium in a patient's sample. This test is particularly crucial in clinical settings for diagnosing infections caused by Proteus vulgaris, which can lead to a range of health issues, including urinary tract infections, wound infections, and even systemic infections. The process involves extracting RNA from the sample and utilizing polymerase chain reaction (PCR) or similar techniques to qualitatively assess the presence of the bacterium's genetic material, thereby confirming an infection.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic technologies and expertise in molecular biology, this test ensures high accuracy and reliability. The cost for the Proteus vulgaris RNA Detection Qualitative Test is set at 1020 AED. Given the critical nature of accurately diagnosing bacterial infections for appropriate treatment, this test represents a valuable tool in the arsenal of healthcare providers. Patients are advised to consult with their healthcare provider to understand the implications of the test results and the subsequent steps in their treatment plan.
The "Salmonella Typhi RNA Detection Qualitative Test" is a sophisticated diagnostic procedure designed to identify the presence of RNA from the Salmonella Typhi bacterium, which is the causative agent of typhoid fever. This test is particularly useful in the early detection of the disease, even before the appearance of specific antibodies, making it a crucial tool for timely intervention and treatment. The test employs cutting-edge molecular techniques to qualitatively assess the presence of the pathogen's RNA, ensuring high specificity and sensitivity in the detection process.
Conducted at DNA Labs UAE, a state-of-the-art facility known for its commitment to advanced diagnostic services, the test offers reliable results. The cost of the test is set at 1020 AED, reflecting the sophisticated technology and expertise required to perform it. Patients seeking an accurate diagnosis of typhoid fever can rely on this test for its precision and the professional handling by the lab's experienced staff, ensuring that individuals receive the necessary medical attention promptly based on the test outcomes.
The Everolimus Test is a specialized diagnostic procedure designed to measure the levels of everolimus, a potent immunosuppressant drug, in the blood. This test is crucial for individuals who are undergoing treatment with everolimus, particularly patients who have undergone organ transplantation or those being treated for certain types of cancers. By monitoring the concentration of the drug, healthcare providers can adjust dosages to optimize therapeutic effects while minimizing potential side effects.
The test involves a simple blood draw, after which the sample is analyzed to determine the concentration of everolimus present. This helps in ensuring that the drug levels remain within a therapeutic range, which is essential for the efficacy of the treatment and the safety of the patient.
At DNA Labs UAE, the Everolimus Test is available for a cost of 1020 AED. The facility is equipped with state-of-the-art technology to ensure accurate and reliable results. DNA Labs UAE is known for its commitment to providing high-quality diagnostic services, making it a trusted choice for patients and healthcare providers seeking to monitor everolimus levels.
The Fever SARS-CoV-2 Panel Test, available at DNA Labs UAE for a cost of 1080 AED, is a comprehensive diagnostic tool designed to detect the presence of the SARS-CoV-2 virus, the causative agent of COVID-19, along with other pathogens that can cause symptoms similar to those of COVID-19. This panel test is particularly useful for individuals experiencing fever and respiratory symptoms, as it helps in distinguishing between COVID-19 and other viral or bacterial infections with overlapping symptoms. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures accurate and timely results, aiding in the appropriate management and treatment of the detected condition. By utilizing advanced molecular diagnostic techniques, the Fever SARS-CoV-2 Panel Test provides a crucial service in the ongoing efforts to control and mitigate the spread of COVID-19 and other infectious diseases.
The FISH (Fluorescence In Situ Hybridization) - 17p TP53 Deletion Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect deletions of the TP53 gene located on the short arm (p) of chromosome 17. This gene plays a crucial role in controlling cell division and preventing tumor growth, and its deletion is associated with various types of cancer, including chronic lymphocytic leukemia (CLL), among others. The test uses fluorescent probes to visualize and map the genetic material in a sample, allowing for the precise identification of genetic abnormalities.
With a cost of 1080 AED, the test is a valuable tool for clinicians in the diagnosis and management of patients with suspected or confirmed malignancies that may involve TP53 deletions. The results from this test can provide essential information for determining prognosis, guiding treatment decisions, and assessing response to therapy. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing, contributing to the advancement of personalized medicine and targeted cancer therapy.
